Dustin Hicks, Carly Baehr, Pedro Silva-Ortiz, Aaron Khaimraj, Diego Luengas, Fatima A. Hamid, & Marco Pravetoni. (2022). Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development. Taylor & Francis Group.
Chicago Style (17th ed.) CitationDustin Hicks, Carly Baehr, Pedro Silva-Ortiz, Aaron Khaimraj, Diego Luengas, Fatima A. Hamid, and Marco Pravetoni. Advancing Humanized Monoclonal Antibody for Counteracting Fentanyl Toxicity Towards Clinical Development. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationDustin Hicks, et al. Advancing Humanized Monoclonal Antibody for Counteracting Fentanyl Toxicity Towards Clinical Development. Taylor & Francis Group, 2022.
Warning: These citations may not always be 100% accurate.